Pharmaceutical intermediates
Varenicline Tartrate Intermediates
4 pharmaceutical intermediates for Varenicline Tartrate. Indication: Nicotine dependence; Smoking cessation; Smoking.
About Varenicline Tartrate
- Originator
- Pfizer Inc
- Indication
- Nicotine dependence; Smoking cessation; Smoking
- Approved Date
- 05/10/2006
Available intermediates
4 intermediates currently listed for Varenicline Tartrate. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| 1,4-DIHYDRO-1,4-METHANONAPHTHALENE | 4453-90-1 | / | / |
| 2,3,4,5-TETRAHYDRO-1H-1,5-METHANO-3-BENZAZEPINE HYDROCHLORIDE | 230615-52-8 | / | / |
| 2,3,4,5-Tetrahydro-7,8-dinitro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine | 230615-59-5 | / | / |
| 2,3,4,5-Tetrahydro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine-7,8-diamine | 230615-69-7 | / | / |
Building toward Varenicline Tartrate?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →